Neuroprotection by 21-aminosteroids: Insights from latencies of anoxic terminal negativity in hippocampus slices of guinea pig

Neurological Research

Volumn 21, Issue 3, 1999, Pages 305-308

  Hülsmann, Swen ^a,b   Köhling, Rüdiger ^a   Greiner, Christoph ^a   Moskopp, Dag ^a   Lücke, Anne ^a   Wassmann, Hansdetlef ^a   Speckmann, Erwin Josef ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

21 Aminosteroids; Cerebral ischemia; DC potential; Hippocampal brain slice; Hypoxia; Neuroprotection

Indexed keywords

21 AMINOSTEROID; 21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; INTRALIPID; NEUROPROTECTIVE AGENT;

ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN SLICE; CEREBROSPINAL FLUID; CONTROLLED STUDY; EVOKED RESPONSE; FEMALE; GUINEA PIG; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; MEMBRANE STABILIZATION; NERVE CELL MEMBRANE STEADY POTENTIAL; NEUROPROTECTION; NONHUMAN;

EID: 17344385586     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.1999.11740936     Document Type: Article

References (23)

1. Luhmann HG. Ischemia and lesion induced imbalances in cortical function. Prog Neurobiol 1996; 48: 131-166
2. Wassmann H, Moskopp D, Woesler B, Lücke A, Speckmann EJ, Köhling R, Straub H, Hülsmann S, Greiner C. Repetitive hypoxic exposure of brain slices and electrophysiological responses as an experimental model for investigation of cerebroprotective measurements. Neurol Res 1996; 18: 367-369
3. Hall ED. Lazaroids: Efficiency and anti-oxidant mechanism in experimental cerebral ischemia. In: Krieglstein J, Oberpichler H, eds. Pharmacology of Cerebral Ischemia 1990, Stuttgart: Wiss. Verlagsges, 1990: pp. 342-350
4. Ringelstein EB. Lazaroide. In: Moskopp D, Wassmann H, eds. Zerebroprotektive Maßnahmen bei Energiekriesen des Hirns, Zülpich: Biermann Verlag, 1994: pp. 1-14
5. McCall JM. The discovery and pharmacology of tirilazad mesylate. Eur J Emerg 1993; 6: 91-95
6. Domenici MR, Longo R, de Carolis AS, Frank C, Sagratella S. Protective actions of 21-aminosteroids and MK-801 on hypoxia-induced electrophysiological changes in rat hippocampal slices. Eur J Pharmacol 1993; 233: 291-293
7. Caspers H, Speckmann E-J, Lehmenkühler A. DC potentials of the cerebral cortex. Seizure activity and changes in gas pressures. Rev Physiol Biochem Pharmacol 1987; 106: 127-178
8. Speckmann E-J, Bingmann D, Lehmenkühler A, Lipinski HG. Changes of the bioelectrical activity and extracellular micromilieu in the central nervous system during variations of local oxygen pressure. In: Acker H, ed. Oxygen Sensing in Tissues, Berlin: Springer-Verlag, 1988: pp. 179-191
9. Luhmann HJ, Scheid M. Dextromethorphan attenuates hypoxia-induced neuronal dysfunction in rat neocortical slices. Neurosci Lett 1994; 178: 171-174
10. Hülsmann S, Greiner C, Schmidinger A, Köhling R, Lücke A, Speckmann E-J, Tuxhom I, Wolf P, Pannek H, Oppel F, Moskopp D, Wassmann H. Hypothermia prevents anoxic terminal negativity in human neocortical slices. Pflügers Arch 1997; Suppl.433: R124
11. Greiner C, Hülsmann S, Wassmann H, Moskopp D, Schmidinger A, Wölfer J, Köhling R, Lücke A, Speckmann E-J. Neuroprotection of mild hypothermia: Differential effects. Brain Res 1998; 786: 267-269
12. Wassmann H, Greiner C, Hülsmann S, Moskopp D, Speckmann E-J, Meyer J, Van Aken H. Hypothermia as cerebroprotective measure. Experimental hypoxic exposure of brain slices and clinical application in critically reduced cerebral perfusion pressure. Neurol Res 1998; 20: S61-S65
13. Köhling R, Schmidinger A, Hülsmann S, Vanhatalo S, Lücke A, Straub H, Speckmann E-J, Tuxhom I, Wolf P, Lahl R, Pannek H, Oppel F, Greiner C, Moskopp D, Wassmann H. Anoxic terminal negative DC-shift in human neocortical slices in vitro. Brain Res 1996; 741: 174-179
14. Taylor CP, Burke SP, Weber ML. Hippocampal slices: Glutamate overflow and cellular damage from ischemia are reduced by sodium-channel blockade. J Neurosci Meth 1995; 59: 121-128
15. Kral T, Luhmann HJ, Mittmann T, Heinemann U. Role of NMDA receptors and voltage-activated calcium channels in an in vitro model of cerebral ischemia. Brain Res 1993; 612: 278-288
16. Abramowicz AE, Kass IS, Chambers G, Cottrell JE. Midazolam improves electrophysiological recovery after anoxia and reduces the changes in ATP levels and calcium influx during anoxia in the rat hippocampal slice. Anesthesiology 1991; 74: 1121-1128
17. Hara H, Ozaki A, Yoshidomi M, Sukamoto T. Protective effect of KB-2796, a new calcium antagonist, in cerebral hypoxia and ischemia. Arch Int Pharmacodyn Ther 1990; 304: 206-218
18. Madden KP, Clark WM, Marcoux FW, Probert AW Jr, Weber ML, Rivier J, Zivin JA. Treatment with conotoxin, an 'N-type' calcium channel blocker, in neuronal hypoxic-ischemic injury. Brain Res 1990; 537: 256-262
19. Moskopp D, Wassmann H, Woesler B, Greiner C, Hülsmann S, Marinov M, Lücke A, Köhling R, Straub H, Speckmann E-J. Effekte von Nimodipin bei wiederholten Hypoxien auf die anoxische Negativierung und evozierte Feldpotentiale in Hippokampus-schnitten des Meerschweinchens in vitro. In: Böker DK, ed. Neue Aspekte zu Pathogenese und Therapie des zerebralen Vasospasmus, Zülpich: Biermann, 1996: pp. 158-164
20. Peruche B, Krieglstein J. Mechanisms of drug actions against neuronal damage caused by ischemia - an overview. Prog Neuropsychopharmacol Biol Psychiatry 1993; 17: 21-70
21. Beck T, Bielenberg GW. The effects of two 21-aminosteroids on overt infarct size 48 hours after middle cerebral artery occlusion in the rat. Brain Res 1991; 560: 159-162
22. Watson BD, Busto R, Goldbeg WJ, Santiso M, Ginsberg MD. Lipid peroxidation in vivo induced by reversible global ischemia in the rat brain. J Neurochem 1984; 42: 268-274
23. Taylor CP, Meldrum BS. Na+ channels as targets for neuroprotective drugs. Trends Pharmacol Sci 1995; 16: 309-316